— Know what they know.
Not Investment Advice
Also trades as: MOR.DE (XETRA) · $vol 5M · MPSYF (OTC) · $vol 0M · MOR.SW (SIX)

MOR NASDAQ

MorphoSys AG
1W: +0.0% 1M: +0.4% 3M: +6.1% 1Y: +152.8% 3Y: +43.0% 5Y: -37.6%
$18.96
Last traded 2024-08-09 — delisted
NASDAQ · Healthcare · Biotechnology · $2.9B mcap · 902436 float · 9.19% daily turnover

Balance Sheet Trends

Total Assets
$2.0B -15.5% ▼
5Y CAGR: +30.3%
Total Liabilities
$2.0B -11.7% ▼
5Y CAGR: +108.3%
Shareholders Equity
$49M -68.8% ▼
5Y CAGR: -36.8%
Cash & Investments
$683M -24.7% ▼
5Y CAGR: +13.7%
Total Debt
$636M +87.3% ▲
5Y CAGR: +516.3%
Net Debt
$477M +859.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$44M$110M$123M$402M$158M
Short-Term Investments$228M$981M$870M$505M$524M
Cash & ST Investments$273M$1.1B$994M$907M$683M
Net Receivables$20M$90M$86M$112M$43M
Inventory$288K$10M$21M$24M$62M
Other Current Assets-$40K$10M$16M-$367$0
Total Current Assets$304M$1.2B$1.1B$1.1B$814M
Property, Plant & Equip.$5M$51M$50M$51M$15M
Goodwill & Intangibles$45M$71M$1.2B$1.2B$1.2B
Long-Term Investments$99M$197M$9M$5M$4M
Other Non-Current Assets$44M$2M$4M$9M$1M
Total Non-Current Assets$193M$453M$1.4B$1.3B$1.2B
Total Assets$496M$1.7B$2.6B$2.4B$2.0B
— Liabilities —
Accounts Payable$11M$48M$74M$39M$28M
Short-Term Debt$3M$3M$4M$10M$14M
Deferred Revenue$2M$3M$224K$0$19M
Other Current Liabilities$47M$147M$207M$230M$202M
Total Current Liabilities$62M$200M$285M$278M$264M
Long-Term Debt$40M$315M$322M$330M$622M
Other Non-Current Liab.$23K$518M$1.7B$1.6B$1.1B
Total Non-Current Liabilities$40M$838M$2.0B$2.0B$1.7B
Total Liabilities$102M$1.0B$2.3B$2.2B$2.0B
— Equity —
Common Stock$32M$33M$34M$34M$38M
Retained Earnings-$256M-$158M-$672M-$823M-$1.0B
Accumulated OCI-$1M$2M$53M$115M$88M
Total Stockholders Equity$395M$621M$245M$157M$49M
Total Liabilities & Equity$496M$1.7B$2.6B$2.4B$2.0B
— Key Metrics —
Total Debt$43M$318M$326M$339M$636M
Net Debt-$2M$208M$203M-$63M$477M
Total Investments$327M$1.2B$880M$510M$528M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms